Global Sickle-cell Anemia Therapeutics Market Research Report 2023

Report ID: 1900131 | Published Date: Sep 2024 | No. of Page: 93 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Blood Transfusion
        1.2.3 Pharmacotherapy
        1.2.4 Bone Marrow Transplant
    1.3 Market by User
        1.3.1 Global Sickle-cell Anemia Therapeutics Market Share by User: 2017 VS 2021 VS 2028
        1.3.2 Child
        1.3.3 Adult
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Sickle-cell Anemia Therapeutics Market Perspective (2017-2028)
    2.2 Sickle-cell Anemia Therapeutics Growth Trends by Region
        2.2.1 Sickle-cell Anemia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Sickle-cell Anemia Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Sickle-cell Anemia Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Sickle-cell Anemia Therapeutics Market Dynamics
        2.3.1 Sickle-cell Anemia Therapeutics Industry Trends
        2.3.2 Sickle-cell Anemia Therapeutics Market Drivers
        2.3.3 Sickle-cell Anemia Therapeutics Market Challenges
        2.3.4 Sickle-cell Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Sickle-cell Anemia Therapeutics Players by Revenue
        3.1.1 Global Top Sickle-cell Anemia Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Sickle-cell Anemia Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Sickle-cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Sickle-cell Anemia Therapeutics Revenue
    3.4 Global Sickle-cell Anemia Therapeutics Market Concentration Ratio
        3.4.1 Global Sickle-cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Sickle-cell Anemia Therapeutics Revenue in 2021
    3.5 Sickle-cell Anemia Therapeutics Key Players Head office and Area Served
    3.6 Key Players Sickle-cell Anemia Therapeutics Product Solution and Service
    3.7 Date of Enter into Sickle-cell Anemia Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle-cell Anemia Therapeutics Breakdown Data by Type
    4.1 Global Sickle-cell Anemia Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Type (2023-2028)
5 Sickle-cell Anemia Therapeutics Breakdown Data by User
    5.1 Global Sickle-cell Anemia Therapeutics Historic Market Size by User (2017-2022)
    5.2 Global Sickle-cell Anemia Therapeutics Forecasted Market Size by User (2023-2028)
6 North America
    6.1 North America Sickle-cell Anemia Therapeutics Market Size (2017-2028)
    6.2 North America Sickle-cell Anemia Therapeutics Market Size by Country (2017-2022)
    6.3 North America Sickle-cell Anemia Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Sickle-cell Anemia Therapeutics Market Size (2017-2028)
    7.2 Europe Sickle-cell Anemia Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Sickle-cell Anemia Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Sickle-cell Anemia Therapeutics Market Size (2017-2028)
    9.2 Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Addmedica
        11.1.1 Addmedica Company Detail
        11.1.2 Addmedica Business Overview
        11.1.3 Addmedica Sickle-cell Anemia Therapeutics Introduction
        11.1.4 Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.1.5 Addmedica Recent Development
    11.2 Gamida Cell
        11.2.1 Gamida Cell Company Detail
        11.2.2 Gamida Cell Business Overview
        11.2.3 Gamida Cell Sickle-cell Anemia Therapeutics Introduction
        11.2.4 Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.2.5 Gamida Cell Recent Development
    11.3 GlycoMimetics
        11.3.1 GlycoMimetics Company Detail
        11.3.2 GlycoMimetics Business Overview
        11.3.3 GlycoMimetics Sickle-cell Anemia Therapeutics Introduction
        11.3.4 GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.3.5 GlycoMimetics Recent Development
    11.4 Pfizer
        11.4.1 Pfizer Company Detail
        11.4.2 Pfizer Business Overview
        11.4.3 Pfizer Sickle-cell Anemia Therapeutics Introduction
        11.4.4 Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.4.5 Pfizer Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Detail
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Sickle-cell Anemia Therapeutics Introduction
        11.5.4 Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.5.5 Novartis Recent Development
    11.6 Global Blood Therapeutics
        11.6.1 Global Blood Therapeutics Company Detail
        11.6.2 Global Blood Therapeutics Business Overview
        11.6.3 Global Blood Therapeutics Sickle-cell Anemia Therapeutics Introduction
        11.6.4 Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.6.5 Global Blood Therapeutics Recent Development
    11.7 Micelle BioPharma
        11.7.1 Micelle BioPharma Company Detail
        11.7.2 Micelle BioPharma Business Overview
        11.7.3 Micelle BioPharma Sickle-cell Anemia Therapeutics Introduction
        11.7.4 Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.7.5 Micelle BioPharma Recent Development
    11.8 Bluebird Bio
        11.8.1 Bluebird Bio Company Detail
        11.8.2 Bluebird Bio Business Overview
        11.8.3 Bluebird Bio Sickle-cell Anemia Therapeutics Introduction
        11.8.4 Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.8.5 Bluebird Bio Recent Development
    11.9 Prolong Pharmaceuticals
        11.9.1 Prolong Pharmaceuticals Company Detail
        11.9.2 Prolong Pharmaceuticals Business Overview
        11.9.3 Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Introduction
        11.9.4 Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.9.5 Prolong Pharmaceuticals Recent Development
    11.10 Modus Therapeutics
        11.10.1 Modus Therapeutics Company Detail
        11.10.2 Modus Therapeutics Business Overview
        11.10.3 Modus Therapeutics Sickle-cell Anemia Therapeutics Introduction
        11.10.4 Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.10.5 Modus Therapeutics Recent Development
    11.11 Sangamo Biosciences
        11.11.1 Sangamo Biosciences Company Detail
        11.11.2 Sangamo Biosciences Business Overview
        11.11.3 Sangamo Biosciences Sickle-cell Anemia Therapeutics Introduction
        11.11.4 Sangamo Biosciences Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.11.5 Sangamo Biosciences Recent Development
    11.12 Bioverativ
        11.12.1 Bioverativ Company Detail
        11.12.2 Bioverativ Business Overview
        11.12.3 Bioverativ Sickle-cell Anemia Therapeutics Introduction
        11.12.4 Bioverativ Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.12.5 Bioverativ Recent Development
    11.13 Imara
        11.13.1 Imara Company Detail
        11.13.2 Imara Business Overview
        11.13.3 Imara Sickle-cell Anemia Therapeutics Introduction
        11.13.4 Imara Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.13.5 Imara Recent Development
    11.14 Ironwood Pharmaceuticals
        11.14.1 Ironwood Pharmaceuticals Company Detail
        11.14.2 Ironwood Pharmaceuticals Business Overview
        11.14.3 Ironwood Pharmaceuticals Sickle-cell Anemia Therapeutics Introduction
        11.14.4 Ironwood Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022)
        11.14.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Blood Transfusion
    Table 3. Key Players of Pharmacotherapy
    Table 4. Key Players of Bone Marrow Transplant
    Table 5. Global Sickle-cell Anemia Therapeutics Market Size Growth by User (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Sickle-cell Anemia Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Sickle-cell Anemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Sickle-cell Anemia Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Sickle-cell Anemia Therapeutics Market Share by Region (2023-2028)
    Table 11. Sickle-cell Anemia Therapeutics Market Trends
    Table 12. Sickle-cell Anemia Therapeutics Market Drivers
    Table 13. Sickle-cell Anemia Therapeutics Market Challenges
    Table 14. Sickle-cell Anemia Therapeutics Market Restraints
    Table 15. Global Sickle-cell Anemia Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Sickle-cell Anemia Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Sickle-cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle-cell Anemia Therapeutics as of 2021)
    Table 18. Ranking of Global Top Sickle-cell Anemia Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Sickle-cell Anemia Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Sickle-cell Anemia Therapeutics Product Solution and Service
    Table 22. Date of Enter into Sickle-cell Anemia Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Sickle-cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Sickle-cell Anemia Therapeutics Market Size by User (2017-2022) & (US$ Million)
    Table 29. Global Sickle-cell Anemia Therapeutics Revenue Market Share by User (2017-2022)
    Table 30. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by User (2023-2028) & (US$ Million)
    Table 31. Global Sickle-cell Anemia Therapeutics Revenue Market Share by User (2023-2028)
    Table 32. North America Sickle-cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Sickle-cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Sickle-cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Sickle-cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Addmedica Company Detail
    Table 43. Addmedica Business Overview
    Table 44. Addmedica Sickle-cell Anemia Therapeutics Product
    Table 45. Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. Addmedica Recent Development
    Table 47. Gamida Cell Company Detail
    Table 48. Gamida Cell Business Overview
    Table 49. Gamida Cell Sickle-cell Anemia Therapeutics Product
    Table 50. Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Gamida Cell Recent Development
    Table 52. GlycoMimetics Company Detail
    Table 53. GlycoMimetics Business Overview
    Table 54. GlycoMimetics Sickle-cell Anemia Therapeutics Product
    Table 55. GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. GlycoMimetics Recent Development
    Table 57. Pfizer Company Detail
    Table 58. Pfizer Business Overview
    Table 59. Pfizer Sickle-cell Anemia Therapeutics Product
    Table 60. Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Pfizer Recent Development
    Table 62. Novartis Company Detail
    Table 63. Novartis Business Overview
    Table 64. Novartis Sickle-cell Anemia Therapeutics Product
    Table 65. Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Novartis Recent Development
    Table 67. Global Blood Therapeutics Company Detail
    Table 68. Global Blood Therapeutics Business Overview
    Table 69. Global Blood Therapeutics Sickle-cell Anemia Therapeutics Product
    Table 70. Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Global Blood Therapeutics Recent Development
    Table 72. Micelle BioPharma Company Detail
    Table 73. Micelle BioPharma Business Overview
    Table 74. Micelle BioPharma Sickle-cell Anemia Therapeutics Product
    Table 75. Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Micelle BioPharma Recent Development
    Table 77. Bluebird Bio Company Detail
    Table 78. Bluebird Bio Business Overview
    Table 79. Bluebird Bio Sickle-cell Anemia Therapeutics Product
    Table 80. Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Bluebird Bio Recent Development
    Table 82. Prolong Pharmaceuticals Company Detail
    Table 83. Prolong Pharmaceuticals Business Overview
    Table 84. Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Product
    Table 85. Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Prolong Pharmaceuticals Recent Development
    Table 87. Modus Therapeutics Company Detail
    Table 88. Modus Therapeutics Business Overview
    Table 89. Modus Therapeutics Sickle-cell Anemia Therapeutics Product
    Table 90. Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. Modus Therapeutics Recent Development
    Table 92. Sangamo Biosciences Company Detail
    Table 93. Sangamo Biosciences Business Overview
    Table 94. Sangamo Biosciences Sickle-cell Anemia TherapeuticsProduct
    Table 95. Sangamo Biosciences Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. Sangamo Biosciences Recent Development
    Table 97. Bioverativ Company Detail
    Table 98. Bioverativ Business Overview
    Table 99. Bioverativ Sickle-cell Anemia TherapeuticsProduct
    Table 100. Bioverativ Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 101. Bioverativ Recent Development
    Table 102. Imara Company Detail
    Table 103. Imara Business Overview
    Table 104. Imara Sickle-cell Anemia TherapeuticsProduct
    Table 105. Imara Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. Imara Recent Development
    Table 107. Ironwood Pharmaceuticals Company Detail
    Table 108. Ironwood Pharmaceuticals Business Overview
    Table 109. Ironwood Pharmaceuticals Sickle-cell Anemia TherapeuticsProduct
    Table 110. Ironwood Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 111. Ironwood Pharmaceuticals Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sickle-cell Anemia Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Blood Transfusion Features
    Figure 3. Pharmacotherapy Features
    Figure 4. Bone Marrow Transplant Features
    Figure 5. Global Sickle-cell Anemia Therapeutics Market Share by User in 2021 & 2028
    Figure 6. Child Case Studies
    Figure 7. Adult Case Studies
    Figure 8. Sickle-cell Anemia Therapeutics Report Years Considered
    Figure 9. Global Sickle-cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Sickle-cell Anemia Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Sickle-cell Anemia Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Sickle-cell Anemia Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Sickle-cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle-cell Anemia Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Sickle-cell Anemia Therapeutics Revenue in 2021
    Figure 15. North America Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Sickle-cell Anemia Therapeutics Market Share by Country (2017-2028)
    Figure 17. United States Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Sickle-cell Anemia Therapeutics Market Share by Country (2017-2028)
    Figure 21. Germany Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Sickle-cell Anemia Therapeutics Market Share by Region (2017-2028)
    Figure 29. China Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Sickle-cell Anemia Therapeutics Market Share by Country (2017-2028)
    Figure 37. Mexico Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Sickle-cell Anemia Therapeutics Market Share by Country (2017-2028)
    Figure 41. Turkey Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Addmedica Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 44. Gamida Cell Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 45. GlycoMimetics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 46. Pfizer Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 48. Global Blood Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 49. Micelle BioPharma Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 50. Bluebird Bio Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 51. Prolong Pharmaceuticals Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 52. Modus Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 53. Sangamo Biosciences Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 54. Bioverativ Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 55. Imara Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 56. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
Frequently Asked Questions
Sickle-cell Anemia Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sickle-cell Anemia Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sickle-cell Anemia Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports